等待開盤 01-03 09:30:00 美东时间
-3.290
-0.94%
Medical technology is experiencing a paradigm shift as artificial intelligence ...
01-01 00:13
Stryker (NYSE:SYK) has outperformed the market over the past 10 years by 1.46% ...
2025-12-29 22:21
今日重点评级关注:HC Wainwright & Co.:维持Pyxis Oncology"买入"评级,目标价从5美元升至7美元;Stifel:维持Oculis Holding"买入"评级,目标价从35美元升至40美元
2025-12-22 15:05
Citizens analyst David Turkaly upgrades Stryker (NYSE:SYK) from Market Perform to Market Outperform and announces $440 price target.
2025-12-19 21:36
今日重点评级关注:Ascendiant Capital:维持Society Pass"买入"评级,目标价从22美元升至22.5美元;HC Wainwright & Co.:维持Climb Bio"买入"评级,目标价从9美元升至11美元
2025-12-19 10:15
- Reuters
2025-12-19 00:27
今日重点评级关注:HC Wainwright & Co.:维持Moleculin Biotech"买入"评级,目标价从4美元升至22美元;HC Wainwright & Co.:上调Soluna Holdings评级至"买入",目标价5美元
2025-12-12 10:24
Citigroup analyst Joanne Wuensch maintains Stryker (NYSE:SYK) with a Buy and lowers the price target from $455 to $420.
2025-12-12 05:06
Stryker announced a quarterly dividend of $0.88 per share, a 4.8% increase from the prior year and previous quarter. The dividend will be payable on January 30, 2026, to shareholders of record as of December 31, 2025. CEO Kevin Lobo emphasized the company's confidence in its financial performance and its capital allocation priorities. Stryker, a global leader in medical technologies, impacts over 150 million patients annually through its innovati...
2025-12-11 13:00
Stryker (NYSE:SYK) has outperformed the market over the past 20 years by 1.85% ...
2025-12-09 07:15